Genzyme

Sanofi Genzyme UK medical boss Marc Moodley discusses oncology plans, NICE and Brexit

https://pharmaphorum.com/views-analysis-oncology/sanofi-genzyme-uk-medical-boss-marc-moodley-discusses-oncology-plans-nice-and-brexit/

Sanofi settles dispute with Genzyme investors over MS drug

https://pharmaphorum.com/news/sanofi-settles-dispute-with-genzyme-investors-over-ms-drug/

Sanofi Q1 growth driven by Genzyme

https://pharmaphorum.com/news/sanofi-q1-growth-driven-by-genzyme/

Sanofi and Alnylam conclude research phase of RNAi alliance

https://pharmaphorum.com/news/sanofi-and-alnylam-conclude-research-phase-of-rnai-alliance/

Sanofi expects growth as rare disease drugs boost earnings

https://pharmaphorum.com/news/sanofi-expects-growth-as-rare-disease-drugs-boost-earnings/

Sanofi beats expectations, driven by rare diseases and vaccines

https://pharmaphorum.com/news/sanofi-beats-expectations-driven-rare-diseases-vaccines/

Vericel hopes for US hit with Maci knee treatment

https://pharmaphorum.com/transversal-categories/us/vericel-hopes-us-hit-maci-knee-treatment/

Close in 10 seconds

Pharmaphorum.com

Search